Publicações Selecionadas

2021

Silva, I. R., Kronenberger, T., Gomes, E. C., César, I. C., Oliveira, R. B., Maltarollo, V. G. (2021). Improving the solubility of an antifungal thiazolyl hydrazone derivative by cyclodextrin complexation. European Journal of Pharmaceutical Sciences156, 105575. DOI: 10.1016/j.ejps.2020.105575

 

2020

Andrade, M. M., Martins, L. C., Marques, G. V., Silva, C. A., Faria, G., Caldas, S., dos Santos, J. S. C., Leclercq, S. Y., Maltarollo, V. G., Ferreira, R. S., Oliveira, R. B. (2020). Synthesis of quinoline derivatives as potential cysteine protease inhibitors. Future medicinal chemistry12(7), 571-581. DOI: 10.4155/fmc-2019-0201

Asse Junior, L. R., Kronenberger, T., Magalhaes Serafim, M. S., Sousa, Y. V., Franco, I. D., Valli, M.,  Bolzani, V. S., Monteiro, G. C., Prates, J. L. B., Kroon, E. G., Mota, B. E. F., Ferreira, D. S., Oliveira, R. B., Maltarollo, V. G. (2020). Virtual screening of antibacterial compounds by similarity search of Enoyl-ACP reductase (FabI) inhibitors. Future medicinal chemistry12(1), 51-68. DOI: 10.4155/fmc-2019-0158

 

2019

Serafim, M. S., Lavorato, S. N., Kronenberger, T., Sousa, Y. V., Oliveira, G. P., Dos Santos, S. G., Kroon, E. G., Maltarollo, V. G.,  Alves, R. J., Mota, B. E. (2019). Antibacterial activity of synthetic 1, 3‐bis (aryloxy) propan‐2‐amines against Gram‐positive bacteria. MicrobiologyOpen8(11), e814. DOI: 10.1002/mbo3.814

 

2018

Lino, C. I., de Souza, I. G., Borelli, B. M., Matos, T. T. S., Teixeira, I. N. S., Ramos, J. P., Fagundes, E. M. S., Fernandes, P. O., Maltarollo, V. G., Johann, S., Oliveira, R. B. (2018). Synthesis, molecular modeling studies and evaluation of antifungal activity of a novel series of thiazole derivatives. European journal of medicinal chemistry151, 248-260. DOI: 10.1016/j.ejmech.2018.03.083

 

2017

Braga, S. F. P., Martins, L. C., da Silva, E. B., Júnior, P. A. S., Murta, S. M. F., Romanha, A. J., Soh, W. T., Brandstetter, H., Oliveira, R. B. (2017). Synthesis and biological evaluation of potential inhibitors of the cysteine proteases cruzain and rhodesain designed by molecular simplification. Bioorganic & medicinal chemistry25(6), 1889-1900. DOI: 10.1016/j.bmc.2017.02.009

Rolar para cima